New trial for liver cancer

[Guest guest]

If you know of anyone who is suffering from liver cancer, you may want to

forward this email to them.

" Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology

and dermatology biopharmaceutical company, has initiated a Phase 1 study of

PV-10 for liver cancer. The study will enroll up to six subjects with cancer

metastatic to the liver or with recurrent liver cancer. PV-10 is the company's

lead oncology drug candidate that is also currently undergoing Phase 2 study for

metastatic melanoma. "

http://www.medicalnewstoday.com/articles/166100.php

FYI,

Lottie Duthu